2.72
C 4 Therapeutics Inc (CCCC) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
10.71%
6.463
|
7.238 | 15.36 | 12.01 | 3.039 |
|
3.95%
34.96
|
36.40 | 43.61 | 33.45 | 35.26 |
Benefits Costs and Expenses |
3.21%
32.48
|
33.56 | 40.03 | 29.72 | 31.40 |
Costs And Expenses |
3.21%
32.48
|
33.56 | 40.03 | 29.72 | 31.40 |
Operating Income/Loss |
2.27%
-28.50
|
-29.16 | -28.24 | -21.44 | -32.22 |
Nonoperating Income/Loss |
12.70%
2.481
|
2.842 | 3.578 | 3.726 | 3.858 |
Income/Loss From Continuing Operations Before Tax |
1.15%
-26.02
|
-26.32 | -24.67 | -17.72 | -28.36 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
1.15%
-26.02
|
-26.32 | -24.67 | -17.72 | -28.36 |
|
1.15%
-26.02
|
-26.32 | -24.67 | -17.72 | -28.36 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.24%
71.01
|
70.83 | 69.63 | 68.81 | 68.43 |
Diluted Average Shares |
0.24%
71.01
|
70.83 | 69.63 | 68.81 | 68.43 |
Basic Earnings Per Share |
0.00%
-0.37
|
-0.37 | -0.35 | -0.26 | -0.41 |
Diluted Earnings Per Share |
0.00%
-0.37
|
-0.37 | -0.35 | -0.26 | -0.41 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):